Geodon approved for adjunctive maintenance treatment of bipolar I disorder
The FDA has approved Geodon (ziprasidone HCl, from Pfizer) capsules for the maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.